Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

• Status: Enrolling by invitation
• Trial end date: 2022-01-25
• Target enrollment: 0
• Participant gender: All

Summary

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rothman Institute Orthopaedics
• Treatments: Meloxicam

Criteria

Inclusion Criteria:

• Age ≥ 18

• Scheduled for arthroscopic labrum repair of the shoulder

Exclusion Criteria:

• History of opioid, acetaminophen, NSAID or local anesthetic allergy or intolerance, or contraindications to these medications.

• Currently on long-term preoperative narcotics

• Scheduled for revision arthroscopic repairs of the shoulder

• Unable/unwilling to consent for enrollment

• Unable to complete postoperative surveys

• History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc)

• Patients under the age of 18

• Pregnant or breastfeeding women

• Scheduled for concurrent procedures